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Received 2 March 2016; revised 22 March 2016; accepted 24 March 2016AbstractAge-related hearing loss (AHL), or presbycusis, is the most common neurodegenerative disorder and top communication deficit of the aged
population. Genetic predisposition is one of the major factors in the development of AHL. Generally, AHL is associated with an age-dependent
loss of sensory hair cells, spiral ganglion neurons and stria vascularis cells in the inner ear. Although the mechanisms leading to genetic hearing
loss are not completely understood, caspase-family proteases function as important signals in the inner ear pathology. It is now accepted that
mouse models are the best tools to study the mechanism of genetic hearing loss or AHL. Here, we provide a brief review of recent studies on
hearing improvement in mouse models of AHL by anti-apoptotic treatment.
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Age-related hearing loss (AHL) is the most common sen-
sory disorder in the elderly population, causing communica-
tion problems and adversely impacting the quality of life of
affected individuals (Gates and Mills, 2005; Yamasoba et al.,
2007; Op de Beeck et al., 2011). Genetic predisposition is
one of the major factors in the development of AHL andgy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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have been conducted recently (Newman et al., 2012;
Yamasoba et al., 2013). As mice and humans share similar
genetic components, anatomic structures and pathological
characteristics, mouse models play a crucial role in under-
standing the pathogenesis associated with these genes (Angeli
et al., 2012; Han et al., 2015). In fact, most inbred mouse
strains display at least some degree of AHL, and the age of the
onset is known to vary from 3 months in DBA/2J mice to over
20 months in CBA/CaJ mice (Zheng et al., 1999; Noben-
Trauth and Johnson, 2009). Part of the early onset of hear-
ing loss in these mice is explained through the presence of a
recessive ahl allele in the gene of cadherin 23 (Cdh23).
Cdh23, also known as gene of otocadherin, encodes for a
calcium-dependent cell adhesion protein (CDH23) that is
required for establishing and/or maintaining the proper orga-
nization of the stereocilia bundle of hair cells in the cochlea
and the vestibule during late embryonic/early postnatal
development. CDH23 and protocadherin 15 (PCDH15)
interact to form the tip links in the stereocilia. They localize,
respectively, to the upper and lower parts of tip links
(Kazmierczak et al., 2007). Altered adhesion or reduced sta-
bility of CDH23 may confer susceptibility to AHL (Noben-
Trauth et al., 2003). It is concluded that the cadherin 23ahl
(Cdh23ahl) allele is associated with a rapid progression of
AHL (Johnson et al., 2000; Ohlemiller, 2006; Op de Beeck
et al., 2011). Other mapped loci, such as ahl2 in NOD/LtJ,
ahl4 in A/J and ahl8 in DBA/2J, et al., contribute to the earlier
onset and more rapid progression of hearing loss in these
strains (Noben-Trauth and Johnson, 2009).
Histopathologically and pathophysiologically, AHL may
variably be accompanied by an age-dependent loss of sensory
hair cells, spiral ganglion cells, and degeneration of stria
vascularis cells (Op de Beeck et al., 2011; Yamasoba et al.,
2013). In fact, apoptosis has been identified as the final
common pathway in degradation of the organ of Corti in
several types of genetic hearing loss (Bao and Ohlemiller,
2010; Cheng et al., 2011; Op de Beeck et al., 2011; Laine
et al., 2007; Niu et al., 2007; Tadros et al., 2008; Schwander
et al., 2009). Recent studies on mouse models of AHL, in
particular, have revealed that apoptosis contributes to degen-
eration of cells in the cochlea and anti-apoptotic treatment
improves hearing in these mouse models.
2. Current concept on the mechanism of AHL
development
Although the pathology of hearing loss is very complicated,
extensive genetic and molecular biological studies have pro-
vided considerable insight into understanding the mechanisms
of cell death. Apoptosis in the cochlea may be triggered by
oxidative stress, which produces reactive oxygen species
(ROS), according to a current conceptual model (Yamasoba
et al., 2007). It is accepted that mitochondria are a major
source of ROS and a major site of ROS-induced oxidative
damage, which has been proposed to play a causal role in AHL
(Ohlemiller et al., 1999; Seidman, 2000; Liu and Yan, 2007;Yamasoba et al., 2007; Someya et al., 2009). The aging the-
ory predicts that in the course of time ROS concentration rises
either due to depletion of antioxidant defenders or due to an
elevated ROS formation. This causes mitochondrial damage
and subsequent release of pro-apoptotic factors that finally
induce apoptosis (Op de Beeck et al., 2011). It is hypothesized
that the ROS may induce DNA damage, which results in the
upregulation of P53, causing chronic activation of the mito-
chondrial BAK pathway, ultimately resulting in the triggering
of apoptotic cell death in the cochleae (Someya and Prolla,
2010). However, other studies pointed that multiple cell
death pathways, all potentially linked to oxidative stress, were
involved in hair cells of the auditory organ in aging mice (Sha
et al., 2009). Despite limitations in the various models of
AHL, it appears that ROS formation and apoptosis are key
events in the pathology of AHL (Op de Beeck et al., 2011).
3. Anti-apoptotic treatment in mouse models of AHL3.1. C57BL/6J miceThe C57BL/6J mouse strain is a long-living strain (mean
lifespan of approximately 30 months) and the mostly used
mouse model for studies of aging and age-associated diseases.
It is well known that hearing loss in C57BL/6J mice occurs at
about 9e12 months of age. Genome-wide linkage analyses
have identified an associated locus (mentioned above as ahl )
in D10Mit5 e D10Mit31 interval on Chromosome 10 (Chr 10)
and further genetic mapping delimited the interval to an 830
kilobases (kb) region on Chr10 (Zheng and Johnson, 2001;
Noben-Trauth et al., 2003). Sequencing of genes in this in-
terval identified a functional polymorphism (G753A) in the
coding sequence of Cdh23. This single nucleotide poly-
morphism (SNP) occurs at the last position of exon 7 and
alters the consensus splice site, leading to in-frame skipping of
exon 7. One of the major genetic factors contributing to
hearing loss in C57BL/6J mice is the ahl locus (Johnson et al.,
1997). However, inbred strain variants of the Cdh23 have been
shown to influence the onset and progression of AHL in mice:
the CBA/CaJ-derived Cdh23Ahlþ allele dramatically lessens
hearing loss and hair cell death in an otherwise C57BL/6J
genetic background, but that the C57BL/6J-derived Cdh23ahl
allele has little effect on hearing loss in an otherwise CBA/CaJ
background (Kane et al., 2012). Study also indicated that loci,
in addition to ahl, contributed to the differences in hearing loss
between C57BL/6J and CAST mice. To be specific, although
hearing thresholds in 24-month-old B6. CAST-Ahl mice were
significantly elevated compared to the normal hearing wild-
type CAST/Ei mice, they were still lower than in age-matched
C57BL/6J mice (Keithley et al., 2004). Therefore, Cdh23ahl
homozygosity is necessary but not sufficient on its own to
cause accelerated hearing loss in C57BL/6J mice.
Study has shown that AHL in C57BL/6J mice is mediated,
at least partly, by Bak-dependent mitochondrial apoptosis. It is
speculated that, in response to increased oxidative DNA
damage in the aged cochlea, p53 translocates to mitochondria
and activates BCL2-antagonist/killer1 (Bak), leading to Bak-
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(Someya et al., 2009). Also in this study, oral supplementation
with the mitochondrial antioxidants suppresses Bak expression
in the cochlea, reduces cochlear cell death, and prevents AHL
(details in section of anti-oxidative stress). Thus, induction of
stress-induced apoptotic cell death through activation of a
Bak-dependent mitochondrial apoptotic program in response
to oxidative stress may be a key mechanism of AHL in
C57BL/6J mice (Someya et al., 2009).3.2. A/J miceA/J mice and C57BL/6J mice share the same ahl allele
(Noben-Trauth et al., 2003). However, mice of the A/J sub-
strain exhibit an early-onset progressive hearing loss with
elevated auditory-evoked brainstem response (ABR) thresh-
olds by 25 days of age, and hearing impairment progresses to
near deafness by three months of age (Zheng et al., 1999,
2009). Therefore, additional genetic factors must be
involved. Sequencing of the mitochondrial genome revealed a
single nucleotide insertion in the tRNA-Arg gene (mt-Tr) that
is likely responsible for the phenotypic effect (Johnson et al.,
2001). However, the effect of the ahl locus combined with the
mitochondrial effect is still not enough to account for the full
extent of hearing loss exhibited by A/J mice. Linkage back-
cross was used to map yet another age-related hearing loss
locus (named ahl4) to the distal region of Chr10 (Zheng et al.,
2009). As was the case with mt-Tr, the ahl4 effect on hearing
loss was limited to backcross mice with predisposing ahl/ahl
genotypes. The ahl4 locus, which could explain about 40% of
the ABR threshold variation in these mice, was then identified
as a mutation in gene of citrate synthase (CS, p.H55N)
(Noben-Trauth and Johnson, 2009; Johnson et al., 2012).
In a recent study, we firstly showed that A/J mice displayed
more severe degeneration of hair cells, spiral ganglion neurons
(SGNs) and stria vascularis in the cochleae compared with
C57BL/6J mice (Han et al., 2015). We then tried to figure out
the reasons for the pathological impairment in A/J mice. Our
results indicate that apoptosis in cochlea is related to the early
onset of hearing loss in A/J mice. As A/J mice are a model of
AHL, a time course caspase dependent and independent
molecules were detected in this mouse. We showed that
apoptosis signals of caspase-3, caspase-9 and Aif (apoptosis-
inducing factor) were at high levels in the inner ears of A/J
mice even at postnatal day 1 (P1), and were significant higher
than those of C57BL/6J mice at 2 and 8 weeks of age, indi-
cating that apoptosis occurs at early stage of inner ear devel-
opment in A/J mice.
The results of anti-apoptosis treatment improving hearing
further support the idea that hearing loss in A/J mice is related
to apoptosis in the inner ears. Z-VAD-FMK (z-Val-Ala-Asp
(Ome)-fluoromethylketone) is a pan-caspase inhibitor that
suppresses the activities of a range of caspases including
caspase-3. It has been documented that Z-VAD-FMK pro-
tected against 3-NP-induced hearing loss through inhibiting
progressive degeneration of the lateral-wall fibrocytes in the
cochlear basal turn, as well as apoptosis of these fibrocytes(Mizutari et al., 2008). There was also study that early direct
perfusion of Z-VAD-FMK into cochlea leads to accelerated
hearing recovery and reduced hair cell loss in guinea pigs
suffering gunshot noise-induced trauma (Abaamrane et al.,
2011). Later study showed that intra-cerebro-ventricular
administration of Z-VAD-FMK to post-radiation rats resulted
in reduced numbers of TUNEL-positive cells in the hypo-
glossal nucleus, suppressed expression and activation of cas-
pases 3/8/9 and decreased appearance of cytochrome c in the
cytosolic fraction (Li et al., 2014). In our study, Z-VAD-FMK
was given intraperitoneally (1.5 mg/g mouse weight) beginning
at P7 for a period of 8 weeks. The drug preserved hearing of
A/J mice by reducing about 15 dB sound pressure level (SPL)
of the ABR thresholds. We thus conclude that caspase-
mediated apoptosis in the cochleae contributes to the early
onset of hearing loss in A/J mice (Han et al., 2015).3.3. DBA/2J miceDBA/2J mice develop early-onset hearing loss with hearing
thresholds elevated by 15e20 dB at 3 weeks of age and
approaching deafness levels by 14 weeks (Zheng et al., 1999).
Apart from ahl, a locus named ahl8 on the distal arm of Chro-
mosome 11 was identified as the main contributor to the early
onset of hearing loss in DBA/2Jmice (Johnson et al., 2008). The
effects of the ahl8 locus on hearing loss in the backcrossed mice
were manifested only in mice with ahl/ahl genotypes (Noben-
Trauth and Johnson, 2009). The ahl8-causative gene was then
identified as fascin-2, which encodes an actin crosslinking
protein previously thought to be retina-specific (Shin et al.,
2010). Fascin-2 cooperates with b-actin to maintain stereo-
cilia length and auditory function. Mice expressing mutant
fascin-2 (p.R109H in DBA/2J mice) or lacking actin share
common phenotypes including progressive, high-frequency
hearing loss together with shortening of a defined subset of
stereocilia in the hair cells (Perrin et al., 2013).
Studies have showed that hearing loss in DBA/2J mice is
paralleled by degeneration of the organ of Corti and spiral
ganglia (Willott et al., 2005). Actually, there are three major
types of AHL: sensory (loss of sensory hair cells), neuronal
(loss of spiral ganglion neurons) and metabolic (strial atrophy)
hearing loss (Yamasoba et al., 2013). Our results demonstrated
that DBA/2J mice displayed at least two features of AHL: loss
of sensory hair cells and spiral ganglion neurons (Yang et al.,
2015). We further found that apoptosis-related genes, espe-
cially Bak and Caspase-3, were highly expressed in inner ears
of DBA/2J mice at 2 weeks of age, preceding hearing loss that
occurred at around 3 weeks of age(Yang et al., 2015). We
therefore suggest that apoptosis in the cochleae of DBA/2J
mice may be related to the activation of Bak-dependent
pathways in mitochondria, which were previously showed in
C57BL/6J mice (Someya et al., 2009; Someya and Prolla,
2010). Moreover, mRNA levels of Caspase-3 and Caspase-9
were higher in the inner ears of DBA/2J mice than those of
C57BL/6J mice at 2 and 8 weeks of age. These results indicate
that apoptosis probably plays a significant role in the hearing
loss of DBA/2J mice.
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in the hearing loss, Z-VAD-FMK was given intraperitoneally to
DBA/J2 mice over an 8-week period starting at oneweek of age.
Blockage of caspases preserved hearing in themice bymore than
10 dBSPL of theABR thresholds and significantly reduced outer
hair cell loss at the basal turns of the cochleae. These results
demonstrate that the hearing loss in DBA/J2 mice can be
attenuated by anti-apoptotic treatment (Yang et al., 2015).3.4. Mouse models of DFNB12Some mouse models of DFNB12 (a form of nonsyndromic
autosomal recessive deafness with mutations in the Cdh23
gene in humans) show AHL and apoptosis is also involved in
the degeneration of cochlea (Noben-Trauth and Johnson,
2009; Schwander et al., 2009; Han et al., 2012). We previ-
ously reported a novel mouse model of DFNB12 with a mu-
tation in Cdh23 (Cdh23erl/erl), which was induced by N-ethyl-
N-nitrosourea (ENU) in the C57BL/6J mouse strain. The
Cdh23erl/erl mice were characterized by progressive hearing
impairment beginning approximately 1 month after birth and
became deaf at 3 months of age. Genetic linkage and
complementation tests demonstrated that erl was a new Cdh23
allele in which a point mutation in exon 3 (208T > C) leads to
a substitution of amino acids (S70P) (Han et al., 2012). mRNA
levels of caspase-3, caspase-8 and caspase-9 were upregulated
in the inner ears of Cdh23erl/erl mouse at P14 and P56,
compared with the levels of C57BL/6J mice. The Cdh23erl/erl
mice were then injected intraperitoneally with Z-VAD-FMK
beginning at P7 for a period of 3 months. The mean per-
centages of outer hair cell loss in the cochleae of Z-VAD-
FMK-treated Cdh23erl/erl mice were significantly reduced
compared to those of untreated or DMSO-treated mice.
Hearing was preserved (ABR thresholds were on average 20-
dB lower) in Z-VAD-FMK-treated Cdh23erl/erl mice compared
to untreated controls (Han et al., 2012).
In a later study, we showed further that erythropoietin (EPO)
had otoprotective effects on the Cdh23erl/erl mice as evaluated
by the measurement of ABR thresholds and amplitudes of
distortion product oto-acoustic emission (DPOAE) (Han et al.,
2013). EPO is a cytokine hormone with multiple functions.
Similar to the way that EPO stimulates erythropoiesis by pro-
tecting the erythroid progenitor cells from apoptosis, its cyto-
protective or otoprotective mechanism appears to be anti-
apoptotic (Vesey et al., 2004; Johnson et al., 2006; Han et al.,
2013). A more recent study showed that systemic treatment
with tauroursodeoxycholic acid (TUDCA), a taurine-
conjugated bile acid, significantly alleviated hearing loss and
suppressed hair cell death in Cdh23erl/erl mice. Additionally,
TUDCA inhibited apoptotic related gene expression in the
cochleae of Cdh23erl/erl mice (Hu et al., 2016).
4. Antioxidants and anti-oxidative stress in mouse models
of AHL
As oxidative stress causes apoptosis in the cochleae, anti-
oxidative stress is important to prevent AHL. Themitochondrial theory of aging postulates that ROS generated
inside of mitochondria damages key mitochondrial compo-
nents, including mitochondrial NDA (mtDNA) and respiratory
chain complex proteins. Such damage accumulates over time
and ultimately leads to permanent age-related mitochondrial
dysfunction, which in turn contributes to the aging phenotypes
(Loeb et al., 2005). In line with this theory is that antioxidant
defenders such as mitochondrial superoxide dismutase 2
(SOD2) decrease significantly with age in all cell types of the
organ of Corti, suggesting that oxidative imbalances indeed
contribute to AHL (Jiang et al., 2007).
The efficacy of the antioxidant systems, e.g., glutathione
and thioredoxin, is an important factor in the pathophysiology
of the aging nervous system (Kang et al., 2012). To explore the
relation between expression of antioxidant-related genes in the
cochlea and AHL in CBA/CaJ mice, expression levels of 56
antioxidant-related genes were analyzed using Affymetrix H
GeneChip (Tadros et al., 2014). The results showed that gene
of glutathione peroxidase 6 (Gpx6) was upregulated while the
gene of thioredoxin reductase 1, (txnrd1) was downregulated
with age/hearing loss. The heat shock protein1 (hspb1) gene
was found to be downregulated in middle-aged animals as well
as those with mild presbycusis, whereas it was upregulated in
those with severe presbycusis. These results may facilitate
development of future interventions to predict, prevent or
slowdown the progression of presbycusis (Tadros et al., 2014).
Experiments in C57BL/6J mice provide evidence that
mitochondrial derived ROS may play a causal role in AHL.
C57BL/6J mice fed with an antioxidant supplemented diet (a
lipoic acid, coenzyme Q and N-acetyl-L-cysteine) showed
significantly lower ABR hearing thresholds when compared to
thresholds from the control mice (Someya et al., 2009).
Furthermore, hearing tests in C57BL/6J mice overexpressing
mitochondrial targeted catalase (MCAT) displayed reduced
ABR thresholds compared to the wildtype mice (Someya
et al., 2009).
AHL is also associated with profound downregulation of
genes involved in the mitochondrial respiratory chain com-
plexes in the cochleae of aged DBA/2J mice (Someya et al.,
2007). Supplementation with antioxidant alpha-lipoic acid
significantly delayed the onset of AHL in DBA/2J mice (Ahn
et al., 2008).
5. Trends and challenges
Genetic factors predispose people to AHL. Only when the
related pathways of a mutant gene are identified, can the
treatment receive better results in animal models. For example,
apoptosis in the cochleae with genetic hearing impairment in
C57BL/6J mice may be linked to mitochondrial related path-
ways (Someya et al., 2009; Someya and Prolla, 2010). Recent
studies reveal that apoptotic signaling may arise from endo-
plasmic reticulum (ER) stress underling functional deficiency
of a particular protein (Xia et al., 2010; Zhang et al., 2010;
Kang et al., 2012; Blanco-Sanchez et al., 2014). Generally,
products of the mutant genes are impaired in trafficking,
leading to ER stress which triggers apoptosis in cells.
11F. Han et al. / Journal of Otology 11 (2016) 7e12Apoptosis is generally involved in the process of cochlear
degeneration. It is a chronic process and anti-apoptotic treat-
ment needs a long period. Meanwhile, more anti-apoptotic
drugs should be screened using the animal models.
According to the current concept, apoptosis is generally
triggered by oxidative stress. Therefore, both anti-apoptotic
agents and antioxidants may be employed in the treatment
of AHL.
Moreover, attempts of genetic therapy for AHL should be
involved in the future study.
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